Ceftazidime (Compound)

Synonyms:ceftazidime, 72558-82-8, Tazidime, Fortaz, Pentacef, Tazicef, Ceptaz, ceftazidima, ceftazidimum, Ceftazidime anhydrous, Ceftazidime pentahydrate, GR 20263, CHEBI:3508, LY 139381, Ceftazidime (INN), Fortaz (TN), (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, (6R,7R)-7-[[2-(2-Amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, 7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, GR-20263, LY-139381, 78439-06-2, CAZ, C22H22N6O7S2, Ceftazidime (TN), Ceptaz (TN), SCHEMBL36849, BIDD:GT0734, CHEMBL44354, DTXSID5022770, J01DD07, HMS2090M13, (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, HY-B0593, BDBM50420259, AKOS015951273, CCG-269983, DB00438, NCGC00179584-05, CEFTAZIDIME (ARGININE FORMULATION), AB00513848, C06889, D07654, AB00513848-02, Cefprozil, Antibiotic for Culture Media Use Only, A839420, Q-200811, (6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(((2-carboxypropan-2-yl)oxy)imino)acetamido)-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (contains ca. 10% Na2CO3), (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl}amino)-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, 1-{[(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetamido]-2-carboxylato-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium, 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-3-(pyridinium-1-ylmethyl)-3,4-didehydrocepham-4-carboxylate

Pubchem:PUBCHEM:54197

Id:4406289f-8abe-5d28-b66f-e4d070f12cb7

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Ceftazidime's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Ceftazidime.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Ceftazidime.

Results found

Linked to

	Label	Description
	DCSTRUCT ID 00559 Collection (Entity type)	DrugPage Collection: (DrugCentralID:00559; PubChem_CID:5481173, FILE=drugcentral_drug_00559.json)
	Ceftazidime positively regulates CD200 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ceftazidime indication Staphylococcal Pneumonia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Ceftazidime positively regulates SERPINB9 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ceftazidime indication Klebsiella cystitis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Ceftazidime negatively regulates G0S2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ceftazidime negatively regulates CHI3L1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ceftazidime indication Sepsis due to Pseudomonas Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Ceftazidime indication Bacterial infection due to Klebsiella pneumoniae Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Ceftazidime negatively regulates SCD Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS